Other Rare Neurological Diseases

IXICO works across many rare neurological diseases and can develop, optimise and apply advanced imaging and analytical techniques to produce disease-focused imaging endpoints.

Example indications include: Spinocerebellar Ataxia (SCA), Friedreich's Ataxia (FA), Amyotrophic Lateral Sclerosis (ALS), and Cerebral Amyloid Angiopathy (CAA). In addition, the IXI™ platform's analysis pipelines can also be optimised for paediatric populations.

Recent Scientific Publications

Neuroimaging Biomarkers for Friedreich's Ataxia: A Cross-Sectional Analysis of the TRACK-FA Study

Date: March 22nd 2025
Synopsis: This study aimed to quantify differences in the brain and spinal cord between individuals with Friedreich's ataxia and healthy controls.
Therapeutic Indication: Friedreich Ataxia

>View Study

MR Imaging in Ataxias: Consensus Recommendations by the Ataxia Global Initiative Working Group on MRI Biomarkers

Date: May 18th 2023
Synopsis: Recommendations for both a basic structural MRI protocol and an advanced multi-modal MRI protocol including acceptable ranges of acquisition parameters for adequate data quality.
Therapeutic Indication: Friedreich Ataxia

>View Study